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Apaf-1, a Human Protein Homologous to
C. elegans CED-4, Participates in
Cytochrome c±Dependent Activation of Caspase-3
Hua Zou,* William J. Henzel,³ Xuesong Liu,* et al., 1996). In mammalian cells, caspase-3 normally
exists as a 32 kd inactive precursor that is convertedAlexis Lutschg,* and Xiaodong Wang*²
proteolytically to a 20 kd and a 10 kd active heterodimer*Department of Biochemistry
when cells are signaled to die (Nicholson et al., 1995;University of Texas Southwestern Medical Center
Schlegel et al., 1996; Wang et al., 1996). Bcl-2, locatedat Dallas
on the outer membrane of mitochondria, prevents the5323 Harry Hines Boulevard
activation of caspase-3 (Boulakia et al., 1996; Chinnai-Dallas, TX 75235
yan et al., 1996; Armstrong et al., 1996; Erhardt and³Division of Protein Chemistry
Cooper, 1996; Ibrado et al., 1996; Monney et al., 1996).Genentech, Inc.
One possible way for Bcl-2 to do this is to block mito-460 Point San Bruno Boulevard
chondria from releasing cytochrome c, a necessary co-South San Francisco, CA 94080-4990
factor for caspase-3 activation (Liu et al., 1996; Yang et
al., 1997; Kluck et al., 1997).
Ced-4 is the only remaining C. elegans general apo-Summary
ptosis gene for which the mammalian counterpart has
not been found. This gene is believed to function down-We report here the purification and cDNA cloning of
stream of ced-9 but upstream of ced-3 in the C. elegansApaf-1, a novel 130 kd protein from HeLa cell cytosol
apoptosis pathway (Shaham and Horvitz, 1996a, 1996b).that participates in the cytochrome c±dependent acti-
The biochemical role of the CED-4 protein is not estab-vation of caspase-3. The NH2-terminal 85 amino acids
lished.of Apaf-1 show 21% identity and 53% similarity to the
We recently established an in vitro system to studyNH2-terminal prodomain of the Caenorhabditis ele-
apoptosis using cytosolic fractions from normally grow-gans caspase, CED-3. This is followed by 320 amino
ing HeLa cells. This system has allowed us to identifyacids that show 22% identity and 48% similarity to
two new protein factors involved in the apoptotic path-CED-4, a protein that is believed to initiate apoptosis
way in mammalian cells. One factor is the previouslyin C. elegans. The COOH-terminal region of Apaf-1
known electron transfer protein, cytochrome c (Liu etcomprises multiple WD repeats, which are proposed
al., 1996). The other is DNA fragmentation factor (DFF),to mediate protein±protein interactions. Cytochrome
a novel heterodimer of 45 and 40 kd subunits that func-c binds to Apaf-1, an event that may trigger the activa-
tions downstream of caspase-3 to trigger fragmentationtion of caspase-3, leading to apoptosis.
of genomic DNA into nucleosomal segments (Liu et al.,
1997), a hallmark of apoptosis (Wyllie, 1980).Introduction
In addition to cytochrome c, the activation of cas-
pase-3 requires another cytosolic factor that we initiallyApoptosis is a form of cell death resulting from the acti-
designated as apoptotic protease activating factor-1
vation of a genetically determined cell suicide program
(Apaf-1; Liu et al., 1996). Cytochrome c has been desig-
(reviewed by Horvitz et al., 1994; Jacobson et al., 1997).
nated as Apaf-2. Subsequent work has resolved Apaf-1
Cells undergoing apoptosis show characteristic morpho-
into two factors. One of these is designated as Apaf-3
logical features such as condensation of cytoplasmic
and the other retains the name Apaf-1 (see Figure 1A).
and nuclear contents, blebbing of plasma membranes,
In the current study, we report the purification, cDNA
fragmentation of nuclei, and ultimately breakdown into
cloning, and characterization of Apaf-1. This 130 kd pro-
membrane-bound apoptotic bodies that are rapidly tein contains a CED-3 homologous domain at the NH2-phagocytosed (Kerr et al., 1972).
terminus, followed by a CED-4 homologous domain, and
Genetic analysis of the nematode Caenorhabditis
multiple WD-40 repeats at the COOH-terminus.
elegans has identified three genes that control the gen-
eral apoptotic program. Two genes, ced-3 and ced-4, Results
are required for the apoptotic program (Yuan and Hor-
vitz, 1990). Ced-9, which functions upstream of ced-3 Fractionation of Cytosol and Reconstitution
and ced-4, negatively regulates the apoptotic program of Caspase-3 Activation
by preventing activation of ced-3 and ced-4 (Hengartner We previously established an in vitro system in which
et al., 1992). the apoptotic program is initiated by the addition of
The apoptotic program delineated in C. elegans is dATP (Liu et al., 1996). The initiation of apoptosis leads
conserved in mammalian cells, which contain homologs to activation of caspase-3 and ultimately to fragmenta-
of ced-9 and ced-3. One of these homologs, Bcl-2, can tion of DNA in nuclei which are coincubated with the
partially substitute for ced-9 in preventing apoptosis in 100,000 3 g supernatant (S-100) cytosolic fraction. Cas-
C. elegans (Hengartner and Horvitz, 1994). The other pase-3 activation was monitored by cleavage of in vitro
homologs, including caspase-3, encode cysteine prote- translated, 35S-labeled, affinity-purified caspase-3 pre-
ases that are closely related to ced-3 (Yuan et al., 1993; cursor. The proteolytic fragments are visualized by SDS-
Fernandes-Alnemri et al., 1994; Xue et al., 1996; Alnemri polyacrylamide gel electrophoresis (PAGE) followed by
phosphorimaging (Figure 1B). Fractionation of the cyto-
sol revealed that one of the required components was²To whom correspondence should be addressed.
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Figure 2. Mono Q Column Purification of Apaf-1
The Apaf-1 activity was purified through the Mono Q column as
described in Experimental Procedures.
(A) Aliquots of 1 ml of Mono Q column fractions were incubated with
aliquots of 4 ml of Apaf-3 (see Figure 1), 1 ml (0.2 mg) of cytochrome
c, 3 ml of in vitro translated, 35S-labeled caspase-3, and 1 mM dATP
at 308C for 1 hr in a final volume of 20 ml of buffer A. After 1 hr at 308C,
Figure 1. Fractionation and Reconstitution of dATP-Dependent Ac- the samples were subjected to 15% SDS-PAGE and transferred to
tivation of Caspase-3 a nitrocellulose filter. The filter was exposed to a Phosphorimaging
HeLa cell S-100 was prepared and fractionated by a Sp-Sepharose plate for 16 hr at room temperature.
and an hydroxylapatite column chromatograph as described in Ex- (B) Aliquots (30 ml) of the indicated Mono Q column fractions were
perimental Procedures. subjected to 8% SDS-PAGE, and the gel was subsequently stained
(A) Schematic illustration of the separation of Apaf-1, -2, and -3. with silver using a Silver Stain Plus kit from Bio-Rad.
(B) Hydroxylapatite column flow-through (Apaf-3) and bound frac-
tions (Apaf-1) were collected and dialyzed against buffer A. Aliquots
of the two fractions (4 ml each) and an aliquot of cytochrome c (0.2 crude Apaf-3 fraction, and the substrate caspase-3.
mg in 1 ml) were incubated individually (lanes 1±3) or in combinations Complete purification of Apaf-1 was achieved through
of two (lanes 4±6) or all three (lanes 7 and 8), in the presence (lanes a six-step procedure (see Experimental Procedures).
1±7) or absence (lane 8) of 1 mM dATP with a 3 ml aliquot of in vitro
The results of the last step of purification, Mono Q col-translated, 35S-labeled caspase-3 at 308C for 1 hr in a final volume
umn chromatography, are shown in Figure 2. Apaf-1of 20 ml of buffer A. The samples were then subjected to 15% SDS-
activity was eluted from the Mono Q column at 250 mMPAGE andtransferred to a nitrocellulose filter. The filter was exposed
to a Phosphorimaging plate for 16 hr at room temperature. NaCl (Figure 2A, fractions 14±16). The same fractions
were subjected to SDS-PAGE followed by silver staining
and a single polypeptide band of z130 kd coeluted withcytochrome c, which was released from mitochondria
the Apaf-1 activity (Figure 2B, fractions 14±16). No otherduring homogenization (Liu et al., 1996).
proteins were detected by silver staining in the peakFigure 1A shows the fractionation scheme that we
fractions. Apaf-1 activity eluted from gel-filtration col-used for the separation of cytochrome c (Apaf-2) from
umns at about 130 kd, indicating that Apaf-1 exists astwo other required factors, Apaf-1 and Apaf-3. The initial
a monomer in solution (data not shown). About 10 mgstep was SP-Sepharose chromatography, which sepa-
of pure Apaf-1 was obtained from the cytosol from 100rated cytochrome c (bound fraction) from Apaf-1 and
liters of HeLa cells.Apaf-3 (flow-through). To separate Apaf-1 and -3, the
flow-through fraction was loaded onto a hydroxylapatite
Sequencing and cDNA Cloning of Apaf-1column. The flow-through and bound fractions were col-
The 130 kd Apaf-1 protein excised from an SDS gellected. Neither fraction alone was competent to activate
was subjected to trypsin and Lys-C digestion, and thecaspase-3 when incubated with cytochrome c and dATP
resulting peptides were separated by capillary reverse-(Figure 1B, lanes 1±6). However, when the bound and
phase high pressure liquid chromatography (HPLC). Theflow-through fractions were mixed in the presence of
sequences of 17 peptides were determined by masscytochrome c and dATP, caspase-3 activation was re-
spectrometry and Edman degradation (Table 1). Proteinstored (Figure 1B, lane 7). No activity was detected when
data base searches revealed no proteins that are identi-dATP and cytochrome c were omitted from the reaction
cal to Apaf-1. Degenerate oligonucleotides encoding(Figure 1B, lanes 5 and 8).
peptides 2 and 4 (see Table 1) were used to prime poly-
merase chain reactions (PCRs) with a HeLa cDNA libraryPurification of Apaf-1
as template. This yielded a 285 bp DNA fragment thatDuring further purification, we assayed Apaf-1 by incu-
bating various fractions with cytochrome c, dATP, the also encoded peptide 3. Probing of a HeLa cDNA li-
A CED-4 Homologous Protein Activates Caspase-3
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Table 1. Peptide Sequences of Human Apaf-1 Purified from Hela Cells
Peptide # Fraction # MH1 Measured MH1 Calculated Residues in cDNA
1 K33a 1780.8 1780.0 5±18
2 K6 1255.7 1255.6 43±52
3 K43 ND 4103.82 82±100
4 T9 913.5 913.5 121±128
5 K46 3153.6ab 3153.6 150±178
6 K42 3160.8a 3161.6 188±213
7 K31 1177.8 1177.7 267±277
8 K29 1450.0 1449.8 292±304
9 K53 2747.1b 2745.4 503±525
10 T24 817.6 817.5 590±596
11 K33b 735.5 735.9 627±632
12 K31 615.3 615.4 639±643
13 K32 1278 1277.7 746±757
14 T17 650.5 650.4 941±945
15 T4a 559.3 558.7 946±949
16 T4b 798.4 797.9 988±994
17 K28 942.7 942.5 1169±1176
Peptides were analyzed by MALDI mass spectrometry and Edman sequencing. The tryptic and Lys-C peptides are designated by the letters
T and K, respectively. The cysteine residues were alkylated with isopropylacetamide.
a Masses represent the average isotopic mass.
b The peptide contained an oxidized tryptophan resulting in an additional 32 daltons.
brary with this PCR fragment identified two overlapping A- and B-box consensus sequences (underlined in Fig-
ure 4C) for nucleotide binding sites (Walker et al., 1982).cDNAs with an open reading frame that encodes 1194
amino acids with a calculated molecular mass of 136,088 Several amino acids that are required for CED-4 activity,
including two aspartic acid residues at positions 250±daltons (Figure 3). Multiple in-frame stop codons were
identified in the 59 untranslated region of the cDNA, 251 and the isoleucineat position258 (Yuan and Horvitz,
indicating that these cDNA clones encode full-length
Apaf-1 (data not shown).
Figure 3 shows the predicted amino acid sequence
encoded by human Apaf-1. The open reading frame of
the cDNA encodes all 17 sequenced peptides that are
distributed throughout the protein (indicated by under-
lines). The measured molecular masses of these pep-
tides by mass spectrometry were consistent with the
calculated molecular masses, indicating that there was
no post-translational modification of these peptides.
Domain Structure of Apaf-1
A search of the protein data base (GenBank and Prosite)
revealed that the COOH-terminal segment of Apaf-1
contains 12 WD-40 repeats (Figure 3, bold). This loosely
conserved set of sequences is found in many regulatory
proteins, including b-subunits of heterotrimeric G pro-
teins (Neer et al., 1994; Wall et al., 1995; Sondek et al.,
1996), the LIS-1 gene for Miller-Dieker Lissencephaly
(Reiner et al., 1993), and the SREBP cleavage-activating
protein (SCAP; Hua et al., 1996).
The searches of the protein data base also revealed
significant similarities between Apaf-1 and CED-3 and
CED-4, two proteins that are required for the apoptotic
program in C. elegans (Yuan and Horvitz, 1990). The
NH2-terminal 85 amino acids of Apaf-1 shows 21% iden-
tity and 53% similarity with the NH2-terminal prodomain
of CED-3 (Figures 4A and 4B). This domain is followed
Figure 3. Amino Acid Sequence of Human Apaf-1 as Predicted from
by a stretch of 320 amino acids that shows 22% identity the cDNA Sequence
and 48% similarity with CED-4 (Figures 4A and 4C). The
Amino acid residues are numbered on the right. Seventeen tryptic
two longest stretches of amino acids conserved with and Lys-C peptides that are found in purified Apaf-1 (Table 1) are
CED-4 lie at positions 141±157 and 227±234 of Apaf-1. underlined. Twelve putative WD-repeats are highlighted in bold
(Neer et al., 1994).These two regions correspond, respectively, to Walker's
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Figure 5. Distribution of Apaf-1 mRNA in Human Tissues
Apaf-1 was hybridized to poly(A)1 RNA from the indicated tissue (2
mg/lane) as described in Experimental Procedures. The left filter
was exposed to a X-ray film with an intensifying screen at 2808C
for 8 days, and the right two filters were exposed to a X-ray film
with an intensifying screen at 2808C for 4 days. The same filters
were subsequently hybridized with human b-actin and exposed to
film for 2 hr (left filter) or 30 min (right two filters) at 2808C with an
intensifying screen. The samples from human adult or fetal tissue
are indicated.
correlating with the high level of apopotosis in these
tissues.
Production of Recombinant Apaf-1
A polyclonal antibody raised against a recombinant pro-
Figure 4. Domain Structure of Apaf-1 tein containing amino acids 10±254 of Apaf-1 reacted
(A) A schematic representation of Apaf-1 is shown by the horizontal with the purified protein (Figure 6A, lane 5). The same
bar, with the numbers corresponding to the amino acid residues in antibody also reacted with the Apaf-1 produced in hu-
Figure 3. The CED-3 and CED-4 homologous regions, the Walker's
man embryonic kidney 293 cells after transfection withA- and B-box consensus sequences for nucleotide binding sites
an expression vector containing human Apaf-1 (Figure(Walker et al., 1982), and 12 WD repeats are indicated.
6A, lanes 2 and 4). Control cells transfected with the(B) The amino acid sequence of the CED-3 homologous region of
Apaf-1 and the NH2-terminal prodomain of CED-3 (Yuan et al., 1993) vector alone show less Apaf-1, representing theendoge-
were aligned by the Lipman-Pearson method of the DNASTAR pro- nous Apaf-1 in 293 cells (Figure 6A, lanes 1 and 3).
gram. Identical amino acids and conserved amino acids are shown The recombinant Apaf-1 migrated to approximately the
by closed and open boxes, respectively.
same position as purified Apaf-1, confirming that the(C) The amino acid sequence of the CED-4 homologous region of
cDNA encoded full-length Apaf-1.Apaf-1 and the amino acids of CED-4 (Yuan and Horvitz, 1992) were
To test the function of recombinant Apaf-1, we co-aligned as above. Identical amino acids and conserved amino acids
are shown by closed and open boxes, respectively. The Walker's transfected a cDNA encoding the hamster caspase-3
A- and B-box consensus sequences for nucleotide binding sites at (Wang et al., 1996) with Apaf-1 in 293 cells. The 32
amino acid residues 143±150 and 228±232 of Apaf-1 are underlined. kd hamster caspase-3 overexpressed in 293 cells was
Asterisks denote the amino acid residues that are known to be
detected by immunoblot analysis with a polyclonal anti-important for CED-4 function (Yuan and Horvitz, 1990; Chinnaiyan
serum against the NH2-terminal region (amino acidset al., 1997).
12±20) of hamster caspase-3 (Wang et al., 1996; Figure
6A, lanes 3 and 4). This antibody does not recognize
human caspase-3 (Figure 6A, lanes 1 and 2; Wang et1992; Chinnaiyan et al., 1997), are conserved in Apaf-1
al., 1996). Interestingly, a higher level of caspase-3 was(Figure 4C, asterisks).
consistently observed when cotransfected with Apaf-1
(Figures 6A and B). One possible explanation for this
observation is that Apaf-1 may bind caspase-3 directlyTissue Distribution of Apaf-1
Figure 5 shows the tissue distribution of Apaf-1 mRNA and slow down its normal turnover rate. No activation
of caspase-3 was observed in vivo by overexpressionanalyzed by Northern blotting of human adult and fetal
tissues. In all tissues examined, including adult brain, of recombinant Apaf-1, confirming that Apaf-1 alone
was not sufficient to trigger caspase-3 activation (Figureheart, liver, spleen, skeletal muscle, lung, pancreas, thy-
mus, small intestine, colon, peripheral blood leukocytes, 6A, lanes 3 and 4). However, when the cell extracts from
Apaf-1 overexpressing cells were incubated with dATP,kidney, testis, ovary and fetal brain, liver, kidney, and
lung, a predominant mRNA of z8 kb nucleotides was caspase-3 was rapidly activated (Figure 6B, lane 8). In
contrast, caspase-3 in the extracts from cells trans-detected, indicating ubiquitous expression of Apaf-1.
Expression was highest in adult spleen and peripheral fected with vector alone was only slightly activated dur-
ing the same period of incubation. These cell extractsblood leukocytes and in fetal brain, kidney, and lung,
A CED-4 Homologous Protein Activates Caspase-3
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Figure 7. Cytochrome c Binds to Apaf-1Figure 6. Expression of Apaf-1 in 293 Cells
Rabbit polyclonal antiserum against Apaf-1 was generated as de-Human embryonic kidney 293 cells were set up and transfected as
scribed in Experimental Procedures. For immunoprecipitation, andescribed in Experimental Procedures.
aliquot of 300 ml of protein A±agarose (Santa Cruz) was incubated(A) 293 cells were transfected with vector alone (lane 1), Apaf-1 (lane
with an aliquot of 500 ml of preimmune or immune serum at 48C2), hamster caspase-3 (lane 3), or Apaf-1 plus hamster caspase-3
overnight. The protein A±agarose beads were then pelleted by cen-(lane 4). The cells were harvested 36 hr after transfection and the
trifigation and washed three times with buffer A. The beads werecytosol was prepared as described in Liu et al. (1996). Aliquots of
resuspended in 300 ml buffer A and incubated with same volume30 mg of cytosol were subjected to 8% SDS-PAGE (upper panel) or
of BSA (1 mg/ml) at 308C for 20 min before use. Aliquots of 100 ml15% SDS-PAGE (lower panel) and blotted onto nitrocellulose filters.
of partially purified Apaf-1 (same as used in Figure 1) were incubatedThe filters were probed with either a rabbit anti-Apaf-1 (1:2000)
alone or with 2 mg of cytochrome c (lanes 3±6) in the absence (lanes(upper panel) or a rabbit anti-hamster caspase-3 (1:2000) (lower
1±4) or presence of 1 mM dATP (lanes 5 and 6) in a final volume ofpanel) antibody, respectively, and the antigen-antibody complexes
200 ml of buffer A at 308C for 20 min followed by the addition of 30were visualized by an ECL method as described in Experimental
ml of antibody±protein A agarose beads prepared as above. In lanesProcedures. The films were exposed for 30 s (upper panel) or 40 s
7 and 8, aliquots of 30 ml of antibody±protein A-agarose beads were(lower panel) respectively. Lane 5 is 3 ml of Apaf-1 protein purified
added to aliquots of 1 ml HeLa cell S-100 fraction directly. Afterto Mono Q column step as described in Experimental Procedures.
incubation at room temperature for 3 hr in a rotator, the mixtures(B) Aliquots of 40 mg of cytosol prepared from 293 cells transfected
were pelleted by centrifigation and the beads were washed fourwith indicated plasmids were incubated either with buffer A (lanes
times with buffer A. The beads were then resuspended in 200 ml of1 and 2) or in the presence of 1 mM dATP (lanes 3 and 4) at 308C
13 SDS loading buffer. After boiling for 3 min, the beads werefor 30 min in a final volume of 20 ml adjusted with buffer A. The
pelleted by centrifigation and the supernatants were collected.samples were subsequently subjected to 15% SDS-PAGE followed
(A) Aliquots of 30 ml of resulting superanatants were subjected toby Western blotting analysis using a rabbit antibody against hamster
8% SDS-PAGE followed by electroblotting to a nitrocellulose filter.caspase-3 (1:2000), and the antigen-antibody complexes were visu-
The filter was probed with the serum against Apaf-1 (1:5000 dilution).alized by an ECL method as described in Experimental Procedures.
The antigen±antibody complexes were visualized by an ECL methodThe film was exposed for 30 s.
as described in Experimental Procedures. The filter was exposed
to a Kodak X-OMAT X-ray film for 5 s.
(B) Aliquots of 30 ml of resulting superanatants were subjected to
15% SDS-PAGE followed by electroblotting to a nitrocellulose filter.contain similar amounts of cytochrome c released dur-
The filter was probed with a monoclonal antibody against cyto-ing homogenization (data not shown).
chrome c as described in Liu et al. (1996). X denotes a cross-reactive
band to this antibody. The antigen±antibody complexes were visual-
ized by an ECL method as described in Experimental Procedures.
Cytochrome c Binds to Apaf-1 The filter was exposed to a Kodak X-OMAT X-ray film for 3 min.
As noted above, the activation of caspase-3 by Apaf-1
and Apaf-3 requires cytochrome c as well as dATP. To
determine whether Apaf-1 interacts directly with cyto- Apaf-1 or cytochrome c. As shown in Figure 7A, antise-
chrome c, we incubated cytochrome c with crude Apaf-1 rum against Apaf-1 precipitated Apaf-1 while the preim-
(same as in Figure 1) and then immunoprecipitated mune serum from the same animal did not. The antise-
the mixture with a polyclonal antiserum against Apaf-1. rum against Apaf-1 also precipitated cytochrome c
The immunoprecipitates were then subjected to SDS- (Figure 7B), indicating that cytochrome c forms a com-
plex with Apaf-1. Preimmune serum caused no suchPAGE and immunoblot analysis with antibodies against
Cell
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precipitation. The binding of cytochrome c to Apaf-1 Apaf-1 Is a Mammalian Homolog of CED-4
Several lines of evidence suggest that Apaf-1 might bewas not influenced by the presence or absence of dATP
the mammalian homolog of CED-4. First, Apaf-1 shows(Figure 7B, lanes 3±6). The precipitation of cytochrome
significant sequence homology with CED-4 over 320c by this antiserum requires the presence of Apaf-1 in
amino acids; second, several important regions ofthe mixture since cytochrome c alone cannot be precipi-
CED-4, including conserved nucleotide binding regionstated by this antibody (data not shown).
and an isoleucine at position 258, are conserved inTo confirm that cytochrome c interacts with Apaf-1
Apaf-1 (Figure 4C); third, the biochemical function ofin the crude cytosolic extracts, the immunoprecipitation
Apaf-1, which is to mediate the activation of caspase-experiment was performed using unfractionated HeLa
3, is consistent with the function of CED-4 as delineatedcell S-100. Apaf-1 in the S-100 fraction was precipitated
by genetic studies. The genetic studies indicate thatby this antiserum (Figure 7A, lanes 7 and 8). Cytochrome
ced-4 functions downstream of ced-9 but upstream ofc, which is released to the cytosol during homogeniza-
ced-3 since the killing of the C. elegans ALM neuronstion (Liu et al., 1996), coprecipitated with Apaf-1 (Figure
by overexpressionof CED-4is greatly reduced ina ced-37B, lane 8). The preimmune serum caused neither pro-
mutant, whereas killing of these neurons by overexpres-tein to precipitate (Figures 7A and 7B, lane 7).
sion of ced-3 is unaffected by mutations in ced-4 (Hen-
gartner et al., 1992; Shaham and Horvitz, 1996a, 1996b).
Similarly, Bcl-2 functions upstream of Apaf-1 by control-Discussion
ling the release of cytochrome c, a cofactor for Apaf-1
activity (Kluck et al., 1997; Yang et al., 1997). In addition,Activation of Caspase-3
the Bcl-2 family of proteins might directly interact withIn the present study, we identified, purified, and cloned a
Apaf-1 in a fashion similar to the interaction between130 kd protein that participated in caspase-3 activation
CED-9 and CED-4 (Chinnaiyan et al., 1997; Wu et al.,reaction in vitro. Caspase-3 normally exists in the cyto-
1997). Such an interaction could negatively or positivelysol of cells as a 32 kd precursor that is activated proteo-
regulate caspase-3 activation mediated by Apaf-1, de-lytically into a 20 kd and a 10 kd heterodimer when cells
pending on the anti- or proapoptosis nature of the pro-are signaled to undergo apoptosis in response to serum
teins.withdrawal, activation of Fas, treatment with ionization,
and a variety of pharmacological agents (Chinnaiyan et
Mechanism for Triggering Caspase-3 Activational., 1996; Datta et al., 1996, 1997; Erhardt and Cooper,
Apaf-1 itself does not seem to be a caspase. The con-1996; Hasegawa et al., 1996; Jacobson et al., 1996;
served active site pentapeptide QACR(or Q/G)G that isSchlegel et al., 1996). The activated caspase-3 is capa-
present in all identified caspases (Alnemri et al., 1996)ble of autocatalysis as well as cleaving and activating
isnot present inApaf-1. An interesting observation madeother members of the caspase family, leading to rapid
by Neer et al. (1994) is that most of the WD repeat-and irreversible apoptosis (Wanget al., 1996; Srinivasula
containing proteins are regulatory and none is an en-et al., 1996). Activated caspase-3 will cleave and activate
zyme. Therefore, the biochemical mechanism for cyto-the 45 kd subunit of DNA fragmentation factor, DFF,
chrome c±triggered caspase-3 activation remains to bewhich in turn leads to the degradation of DNA into
worked out. The eventual understanding will require thenucleosomal fragments (Liu et al., 1997), a hallmark of
purification of Apaf-3 and reconstitution of the cas-apoptosis (Wyllie, 1980).
pase-3 activation reaction with purified factors. TheThe ability of activated caspase-3 to trigger down-
identification of two regions in the ced-4 homologousstream apoptotic events implies that the activation pro-
domain of Apaf-1 that correspond to the Walker's nucle-
cess has to be highly regulated to prevent unwanted
otide binding sites (see Figures 4A and 4C) may explain
cell death. Indeed, Bcl-2 prevents the activation of cas-
the requirement of dATP in the caspase-3 activation
pase-3 in response to a variety of apoptotic signals
reaction. The homology of the NH2-terminal region of(Boulakia et al., 1996; Chinnaiyan et al., 1996; Armstrong Apaf-1 with CED-3 prodomain raises an interesting
et al., 1996; Erhardt and Cooper, 1996; Ibrado et al., question about the evolutionary origin of CED-3 and
1996; Monney et al., 1996). One possible mechanism by CED-4 compared with that of caspase-3 and Apaf-1.
which Bcl-2 prevents the activation of caspase-3 is to The function of this ced-3 homologous region should
prevent cytochrome c release from mitochondria. Con- also be an interesting focus of future studies.
sistent with this possibility, the release of cytochrome Unlike CED-4 of C. elegans, Apaf-1 contains multiple
c from mitochondria in response to apoptotic stimuli is WD repeats in the COOH-terminal region. WD repeats
blocked in cells overexpressing Bcl-2 (Kluck et al., 1997; are involved in protein±protein interactions (Neer et al.,
Yang et al., 1997). 1994; Sondek et al., 1996; Wall et al., 1995). The seven
Once released from mitochondria, cytochrome c WD repeats in the b-subunit of heterotrimeric G protein
binds to Apaf-1, which may trigger the activation of form a circularized 7-fold b propeller. In Giab1g2, blades
caspase-3 in the presence of dATP. Consistent with this of the WD propeller interact with Gia1 subunit and the g
model, cytochrome c was shown to bind to Apaf-1 in a subunit, thereby bridging the heterotrimeric complex
coimmunoprecipitation assay (Figure 7). The levels of (Wall et al., 1995). It is possible that the activation of
Apaf-1 and Apaf-3 do not seem to be regulated by Bcl-2 caspase-3 is through a similar scenario, with the WD
since similar amounts of Apaf-1 and Apaf-3 are found repeats of Apaf-1 bridging cytochrome c and Apaf-3, to
in the cytosol of control and Bcl-2 overexpressing cells induce the de novo activation of caspase-3, leading to
apoptosis.(X. Liu and X. Wang, unpublished observation).
A CED-4 Homologous Protein Activates Caspase-3
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Experimental Procedures aqueous trifluoroacetic acid (TFA) and solvent B is acetonitrile con-
taining 0.07% TFA. The peptides were eluted with a linear gradient
of 0±80% B in 120 min. Peptide peaks were detected at 195 nmGeneral Methods and Materials
and hand collected into 0.5 ml Eppendorf tubes.We obtained dATP and other nucleotides from Pharmacia, radioac-
An aliquot (0.2 ml) of each of the isolated HPLC fractions wastive materials from Amersham, and molecular weight standards for
applied to a premade spot of matrix (0.5 ml of 20 mg/ml a-cyano-SDS-PAGE and gel filtration chromatography from Bio-Rad. Protein
4-hydroxycinammic acid plus 5 mg/ml nitrocellulose in 50% ace-concentrations were determined by the Bradford method; general
tone/50% 2-propanol) on the target plate (Shevchenko et al., 1996).molecular biology methods were used as described in Sambrook
Ions were formed by matrix-assisted laser desorption/ionizationet al. (1989).
with a 337 nm nitrogen laser. Spectra were acquired with a Persep-
tive Biosystems Voyager Elite time-of-flight mass spectrometer, op-
Assay for Caspase-3 Activation erated in linear delayed extraction mode. Subsequently, fragment
Caspase-3 was translated and purified as described (Liu et al., 1996). ions for selected precursor masses were obtained from postsource
A 3 ml aliquot of the in vitro translated caspase-3 was incubated decay (PSD) experiments (Kaufmann et al., 1994). To enhance the
with the indicated protein fraction in the presence of 1 mM dATP ion abundances at low mass, collision gas (air) was introduced to
and 1 mM of additional MgCl2 at 308C for 1 hr in a final volume of the collision cell during the acquisition of the lower portion (,200 Da)
20 ml of buffer A (20 mM HEPES-KOH, pH 7.5, 10 mM KCl, 1.5 mM of the fragment ion spectrum. Each peptide mass and its associated
MgCl2, 1 mM sodium EDTA, 1 mM sodium EGTA, 1 mM dithiothreitol, fragment ion masseswere used to search an in housesequence data
and 0.1 mM PMSF). At the end of the incubation, 7 ml of 43 SDS base with an enhanced version of the FRAGFIT program (Henzel et
sample buffer was added to each reaction. After boiling for 3 min, al., 1993).
each sample was subjected to a 15% SDS-PAGE. The gel was Automated protein sequencing was performedon models Procise
transferred to a nitrocellulose filter, which was subsequently ex- 494A and 494CL Applied Biosystems sequencers equipped with an
posed to a Phosphorimaging plate and visualized in a Fuji BAS- on-line parathyroid hormone (PTH) analyzer. Peaks were integrated
1000 Phosphorimager. with Justice innovation software using Nelson Analytical 760 inter-
faces. Sequence intepretation was performed on a DEC Alpha com-
puter (Henzel et al., 1987).Purification of Apaf-1 from HeLa S-100
All purification steps were carried out at 48C. All chromatography
cDNA Cloning of Apaf-1steps except the SP-Sepharose column (Pharmacia), and first hy-
A 1 ml (108 pfu) aliquot of lExlox HeLa cDNA library (Yokoyama etdroxylapatite column (Bio-Rad) were carried out using an automatic
al., 1993) was heated at 998C for 15 min to release the DNA, whichfast protein liquid chromatography (FPLC) station (Pharmacia).
were directly amplified with 300 pmol of primer-1 59-AA(A/G)GT(A/Seven hundred milliliters (4.9 g of protein) of HeLa S-100 from
T/C/G)(A/C)G(A/T/C/G)AA(T/C)GA(A/G)CC(A/T/C/G)AC-39 and 20100 liters of suspension cultured HeLa cells were prepared as de-
pmol SP6 primer 5-ATTTAGGTGACACTATAGAA-39 using the PCRscribed in Liu et al. (1996) and applied to a SP-Sepharose column
reaction with 5 cycles of 948C for 30 s; 608C for 30 s; and 728C for(200 ml bed volume) equilibrated with buffer A. The 800 ml flow-
1 min followed by 25 cycles of 948C for 30 s; 558C for 30 s; andthrough fraction (3,648 mg of protein) was collected and loaded
728C for 1 min. The PCR product was purified by passing a PCRdirectly onto a hydroxylapaptite column (50-ml bed volume) equili-
Purification column (Qiagen). One-fiftieth of the purified productbrated with buffer A. The column was washed with three column
was further amplified using 300 pmol of primer-2 59-AA(T/C)GA(A/volumes of buffer A containing 1 M NaCl followed by two column
G)CC(A/T/C/G)AC(A/T/C/G)CAACAACA-39 and 300pmol of primer-3volumes of buffer A. The bound material was eluted with 200 ml of
59-TT(T/C)TG(T/C)TG(T/A/G)AT(A/T/C/G)GC(A/G)TTCAC-39 in a0.3 M KPO4, pH 7.5. The protein peak from the column (115 ml, 287
PCR reaction as described above. A 285 bp PCR product was ob-mg of protein) was dialyzed against buffer A and then loaded onto
tained and subsequently sequenced after subcloning into the PCRa second hydroxylapaptite column (10 ml bed volume) equlibrated
II vector using the TA cloning kit (Invitrogen). The 285 bp PCR prod-with buffer A. The column was eluted with a 200 ml buffer A to 250
uct was labeled with [a-32P]dCTP using redi prime RANDOM PrimermM KPO4, pH 7.5 linear gradient followed by a 100 ml, 250 mM to
Labeling kit (Amersham) and used to screen the HeLa lExlox cDNA500 mM KPO4, pH 7.5 linear gradient. Fractions of 10 ml were col-
library by hybridizing duplicate filter at 428C overnight in Rapid-hyblected and assayed for Apaf-1 activity. Active fractions (50 ml, 11
buffer (Amersham). The filters were washed twice with 13 salinemg of protein) were pooled and dialyzed against buffer A and then
citrate (SSC)/0.1% SDS for 15 min at room temperature and onceloaded onto a 5-ml heparin-Sepharose column (Pharmacia) equli-
with 0.53 SSC/0.1% SDS for 10 min at 658C. Out of 6 3 105 plaquesbrated with buffer A. The column was washed with 20 ml of buffer
screened, four positive clones were identified and a 1.4 kb partialA containing 100 mM NaCl and eluted with a 50 ml linear gradient
clone was characterized. The 1.4 kb insert was excised and labeledfrom 100 mM NaCl to 400 mM NaCl, both in buffer A. Fractions of
with [a-32P]dCTP as described above. The same library was re-4 ml were collected and assayed for Apaf-1 activity. The active
screened with this 1.4-kb cDNA fragment as described above. Forty-fractions (8 ml, 0.86 mg of protein) were pooled and loaded directly
five positive clones were identified and characterized. The longestonto a Superdex 200 16/60 gel-filtration column equlibrated with
3 kb clone that contains the 59 part of Apaf-1 was sequenced. Anbuffer A containing 100 mM NaCl. The column was eluted with the
aliquot of 40 ng of this plasmid was amplified by two PCR primers,same buffer (four runs), and fractions of 4 ml were collected starting
APPN 59-ACATCACGAATCTTTCCCGC-39 and APPC 59-AACACTT
from 30 ml of elution. The fractions were assayed for Apaf-1 activity,
CACTATCACTTCC-39, designed from the 39 end of the 3 kb insert.
and the active fractions were pooled (16 ml, 32 mg of protein) and
A 604 bp PCR fragment was generated and labeled with [a-32P]dCTP
loaded directly onto a Mono Q 5/5 column (Pharmacia) equlibrated
as above. The same filters were rescreened with this PCR fragment,
with buffer A containing 100 mM NaCl. The column was eluted with and 35 positive clones were identified and characterized. The lon-
a 20 ml linear gradient from 100 mM NaCl to 300 mM NaCl, both in gest one with an insert of 4.5 kb was sequenced. This clone contains
buffer A. Fractions of 1 ml were collected and assayed for Apaf-1 the 39 part of Apaf-1, which overlaps with the 3 kb 59 clone by 472
activity. bp. The full-length cDNA was obtained by ligating the two clones
at an EcoRI site located within the 472 bp overlapping region.
Protein Sequencing of Apaf-1
The 130 kd band (4±8 pmol) from the Mono Q column was elec- Western Blot Analysis
troblotted onto and excised from a PVDF membrane (ProBlott, Ap- Western blot analysis for cytochrome c was performed as described
plied Biosystem). The band was reduced and alkylated with isopro- previously (Liu et al., 1996). Anti-Apaf-1 antiserum was generated
pylacetamide followed by digestion in 20 ml of 0.05 M ammonium by immunizing rabbits with a recombinant Apaf-1 fusion protein
bicarbonate, 20% acetonitrile with 0.2 mg of trypsin (Promega) or (see below). Immunoblot analysis was performed with a horseradish
Lysine-C (Wako) at 378C for 17 hr as described previously (Henzel peroxidase conjugated goat anti-mouse (cytochrome c) orgoat anti-
et al., 1993). The solution was then directly injected onto a 0.32 3 rabbit (Apaf-1) immunoglobulin G using enhanced chemilumines-
cence Western blotting detection reagents (Amersham).150 mm C18 capillary column (LC Packing, Inc.). Solvent A is 0.1%
Cell
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Production of Apaf-1 Fusion Protein Bai, X., Korsmeyer, S.J., Karanewsky, D.S., Fritz, L.C., andTomaselli,
K.J. (1996). Fas-induced activation of the celldeath-related proteaseThe primers 59-GCAAAAGCTCGAAATCATATGCTTCAACATAGAG-39
and 59-TCGCGGCCGCCTCGAGGGCTCTGGTTGTAAG-39 were de- CPP32 Is inhibited by Bcl-2 and by ICE family protease inhibitors.
J. Biol. Chem. 271, 16850±16855.signed to PCR-amplify the 1.4 kb plasmid Apaf-1cDNA open reading
frame, and the amplified 800 bp fragment encoding amino acids Boulakia, C.A., Chen, G., Ng, F.W., Teodoro, J.G., Branton, P.E.,
10±254 of Apaf-1 was subcloned in-frame into the NdeI±XhoI sites of Nicholson, D.W., Poirier, G.G., and Shore, G.C. (1996). Bcl-2 and
the bacterial expression vector pET-15b (Novagen). The expression adenovirus E1B 19 kDA protein prevent E1A-induced processing of
plasmid was transformed intobacteria BL21(DE3). In a typical Apaf-1 CPP32 and cleavage of poly(ADP-ribose) polymerase. Oncogene
preparation, a 5 ml overnight cultured of bacteria containing Apaf-1 12, 529±535.
expression vector was added into a 500 ml LB broth and cultured Chinnaiyan, A.M., Orth, K., O'Rourke, K., Duan, H., Poirier, G.G., and
for 3 hr by shaking at 220 rpm in 378C. Isopropyl-1-thio-B-D-galacto- Dixit, V.M. (1996). Molecular ordering of the cell death pathway.
pyranoside (IPTG) was added to the culture in a final concentration Bcl-2 and Bcl-xL function upstream of the CED-3-like apoptotic
of 1 mM and shaking continued for another 2 hr. The bacteria were proteases. J. Biol. Chem. 271, 4573±4576.
pelleted by centrifugation, and the bacterial pellet was resuspended
Chinnaiyan, A.M., O'Rourke, K., Lane, B.R., and Dixit, V.M. (1997).in 10 ml of buffer B (6 M GuHCl, 0.1 M sodium phosphate, 0.01 M
Interaction of CED-4 with CED-3 and CED-9: a molecular frameworkTris-HCl, pH 8.0). After centrifugation at 10,000 3 g for 15 min, the
for cell death. Science 275, 1122±1126.supernatant was loaded onto a nickel affinity column (6 ml). The
Datta, R., Banach, D., Kojima, H., Talanian, R.V., Alnemri, E.S., Wong,column was washed with 300 ml buffer B followed by 300 ml buffer
W.W., and Kufe, D.W. (1996). Activation of the CPP32 protease inC (8 M urea, 0.1 M sodium phosphate, 0.01 M Tris-HCl, pH 8.0). The
apoptosis induced by 1-beta-D-arabinofuranosylcytosine and othercolumn was eluted with Buffer C containing 250 mM imidazole.
DNA-damaging agents. Blood 88, 1936±1943.About 10 mg of Apaf-1 protein was purified from a 500-ml culture.
Datta, R., Kojima, H., Banach, D., Bump, N.J.,Talanian, R.V., Alnemri,
Northern Blotting Analysis E.S., Weichselbaum, R.R., Wong, W.W., and Kufe, D.W. (1997). Acti-
Poly(A)1 RNA blots containing 2 mg of poly(A)1 RNA per lane from vation of a CrmA-insensitive, p35-sensitive pathway in ionizing radi-
multiple human adult and fetal tissues were purchased from Clon- ation-induced apoptosis. J. Biol. Chem. 272, 1965±1969.
tech. Blots were hybridized with 2 3 106 cpm/ml random primed Erhardt, P., and Cooper, G.M. (1996). Activation of the CPP32 apo-
604-bp Apaf-1 PCR fragment corresponding to amino acid 590±792 ptoticprotease by distinct signaling pathways with differential sensi-
(amplified with the APPN and APPC primers) in Rapid-hyb buffer tivity to Bcl-xL. J. Biol. Chem. 271, 17601±17604.
(Amersham) at 658C over night. The filters were washed twice with
Fernandes-Alnemri, T., Litwack, G., and Alnemri, E.S. (1994). cpp32,13 SSC/0.5% SDS for 15 min at 658C followed by 0.53 SSC/0.5%
a novel human apoptotic protein with homology to CaenorhabditisSDS for 20 min at 658C. The same filters were also hybridized at
elegans cell death protein CED-3 and mammalian interleukin-1b-658C for 2 hr with a 2.0 kb b-actin cDNA probe, and the filters were
converting enzyme. J. Biol. Chem. 269, 30761±30764.then washed as above.
Hasegawa, J., Kamada, S., Kamiike, W., Shimizu, S., Imazu, T., Mat-
suda, H., and Tsujimoto, Y. (1996). Involvement of CPP32/YamaExpression of Apaf-1 in 293 Cells
(-like) proteases in Fas-mediated apoptosis. Cancer Res. 56, 1713±A 5.7 kb cDNA containing the entire coding region of Apaf-1 plus
1718.577 bp of 59 untranslated region and 1.5 kb of 39 untranslated region
Hengartner, M.O., and Horvitz, R.H. (1994). C. elegans cell survivalwas subcloned into NotI and EcoRI sites of a pcDNA 3.1(2) vector
gene ced-9 encodes a functional homolog of the mammalian proto-(Invitrogen), and the plasmid was designated as pApaf-1 and pre-
oncogene bcl-2. Cell 76, 665±676.pared using a Qiagen Mega plasmid kit. Human embryonic kidney
293 cells were set up at 1 3 106 per 100 mm dish in medium A Hengartner, M.O., Ellis, R.E., and Horvitz, R.H. (1992). Caenorhab-
(Dulbecco's modified Eagle's medium containing 100 U/ml of peni- ditis elegans gene ced-9 protects cells from programmed cell death.
cillin and 100 mg/ml of streptomycin sulfate) supplemented with Nature 356, 494±499.
10% (v/v) fetal calf serum, and grown in monolayer at 378C in an Henzel, W.J., Rodriguez, H., and Watanabe, C. (1987). Complete
atmosphere of 6%±7% CO2. After incubation for 24 hr, each dish analysis of automated Edman degradation amino acid analysis data.
was transfected with either 15 mg of vector alone 10 mg of pApaf-1 J. Chromatogr. 404, 41±52.
plus 5 mg of vector, 10 mg of vector plus 5 mg of pCPP32 (Wang et
Henzel, W.J., Billeci, T.M., Stults, J.T., Wong, S.C., Grimley, C., andal., 1996), or 10 mg of pApaf-1 plus 5 mg of pCPP32 as indicated in
Watanabe, C. (1993). Identifying proteins from two-dimensional gelsthe legend to Figure 6 using the MBS Transfection Kit (Stratagene)
by molecular mass searching of peptide fragments in protein se-as described (Hua et al., 1996). After 36 hr, the cells were harvested,
quence databases. Proc. Natl. Acad. Sci. USA 90, 5011±5015.and the S-100 fractions were prepared as described in Liu et al.
Horvitz, H.R., Shaham, S., and Hengartner, M.O. (1994). The genetics(1996).
of programmed cell death in the nematode Caenorhabditis elegans.
Cold Spring Harbor Symp. Quant. Biol. 59, 377±385.Acknowledgments
Hua, X., Nohturfft, A., Goldstein, J.L., and Brown, M.S. (1996). Sterol
We thank Drs. Peng Li and Austin Gurney for help in the cDNA resistance in CHO cells traced to point mutation in SREBP cleavage-
cloning of Apaf-1. We thank Dr. John T. Stults for helpful discussions activating protein. Cell 87, 415±426.
on interpretation of MS/MS data and James Yashio and Wendy Ibrado, A.M., Huang, Y., Fang, G., Liu, L., and Bhalla, K. (1996).
Schillinglaw for help with peptide sequencing. We are grateful to our Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/
colleagues Drs. Joseph Goldstein and Michael Brown for critically Yama protease activity and apoptosis of human acute myelogenous
reading this manuscript. Suspension cultured HeLa cells were ob- leukemia HL-60 cells. Cancer Res. 56, 4743±4748.
tained from the Cell Culture Center in Minneapolis, MN. X. W. is
Jacobson, M.D., Weil, M., and Raff, M.C. (1997). Programmed cellsupported by an American Cancer Society Research Grant and a
death in animal development. Cell 88, 347±354.Junior Faculty Award.
Kaufmann, R., Kirsch, D., and Spengler, B. (1994). Sequencing of
peptides in a time-of-flight mass spectrometer: evaluation ofReceived June 4, 1997; revised June 30, 1997.
postsource decay following matrix-assisted laser desorption ioniza-
tion (MALDI). International J. Mass Spectrosc. Ion Processes. 131,References
355±385.
Kerr, J.F.R., Wyllie, A.H., and Currie, A.R. (1972). Apoptosis: a basicAlnemri, E.S., Livingston, D.J., Nicholson, D.W., Salvesen, G.,
Thornberry, N.A., Wong, W.W., and Yuan, J. (1996). Human ICE/ biological phenomenon with wide-ranging implication in tissue ki-
netics. Br. J. Cancer 26, 239±257.CED-3 protease nomenclature. Cell 87, 171.
Armstrong, R.C., Aja, T., Xiang, J., Gaur, S., Krebs, J.F., Hoang, K., Kluck, R.M., Bossy-Wetzel, E., Green, D.R., and Newmeyer, D.D.
A CED-4 Homologous Protein Activates Caspase-3
413
(1997). The release of cytochrome c from mitochondria: a primary elegans cell-death protein CED-3 is a cysteine protease with sub-
strate specificities similar to those of human cpp32 protease. Genessite for bcl-2 regulation of apoptosis. Science 275, 1132±1136.
Dev. 10, 1073±1083.Liu, X., Kim, C.N., Yang, J., Jemmerson, R., and Wang, X. (1996).
Yang, J., Liu, X., Bhalla, K., Kim, C.N., Ibrado, A.M., Cai, J., Peng,Induction of apoptotic program in cell-free extracts: requirement for
T-I., Jones, D.P., and Wang, X. (1997). Prevention of apoptosis bydATP and cytochrome c. Cell 86, 147±157.
bcl-2: release of cytochrome c from mitochondria blocked. Science,Liu, X., Zou, H., Slaughter, C., and Wang, X. (1997). DFF, a heterodi-
275, 1129±1132.meric protein that functions downstream of caspase-3 to trigger
Yokoyama, C., Wang, X., Briggs, M.R., Admon, A., Wu, J., Hua, X.,DNA fragmentation during apoptosis. Cell 89, 175±184.
Goldstein, J.L., and Brown, M.S. (1993). SREBP-1, a basic-helix-
Monney, L., Otter, I., Olivier, R., Ravn, U., Mirzasaleh, H., Fellay, I., loop-helix-leucine zipper protein that controls transcription of the
Poirier, G.G., and Borner, C. (1996). Bcl-2 overexpression blocks low density lipoprotein receptor gene. Cell 75, 187±197.
activation of the death protease CPP32/Yama/apopain. Biochem.
Yuan, J.-Y., and Horvitz, R.H. (1990). Genetics mosaic analysis ofBiophys. Res. Commun. 221, 340±345.
ced-3 and ced-4, two genes that control programmed cell death in
Neer, E.J., Schmidt, C.J., Nambudripad, R., and Smith, T.F. (1994). the nematode C. elegans. Dev. Biol. 138, 33±41.
The ancient regulatory-protein family of WD-repeat proteins. Nature
Yuan, J.-Y., and Horvitz, R.H. (1992). The C. elegans cell death gene371, 297±300.
ced-4 encodes a novel protein and is expressed during the period
Nicholson, W.D., Ali, A., Thornberry, N.A., Vailancourt, J.P., Ding, of extensive programmed cell death. Development 116, 309±320.
C.K., Gallant, M., Gareau, Y., Griffin, P.R., Labelle, M., Lazebnik, Yuan, J.-Y., Shaham, S., Ledoux, S., Ellis, M.H., and Horvitz, R.H.
Y.A., Munday, N.A., Raji, S.M., Smulson, M.E., Yamin, T.T., Yu, V.L., (1993). The C. elegans cell death gene ced-3 encodes a protein
and Miller, D.K. (1995). Identification and inhibition of the ICE/CED-3 similar to mammalian interleukin-1b converting enzyme. Cell 75,
protease necessary for mammalian apoptosis. Nature 376, 37±43. 641±652.
Reiner, O., Carrozzo, R., Shen, Y., Wehnert, M., Faustinella, F., Do-
byns, W.B., Caskey, T.C., and Ledbetter, D.H. (1993). Isolation of a GenBank Accession Number
Miller-Dieker lissencephaly gene containing G protein b-subunit-
like repeats. Nature 364, 717±721. The accession number for the Apaf-1 cDNA sequence reported in
this paper is AF013263.Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989). Molecular Clon-
ing A Laboratory Manual, 2nd edition. (Cold Spring Harbor, NY: Cold
Spring Harbor Laboratory Press).
Schlegel, J., Peters, I., Orrenius, S., Miller, D.K., Thornberry, N.A.,
Yamin, T.T., and Nicholson, D.W. (1996). CPP32/apopain is a key
interleukin 1 beta converting enzyme-like protease involved in Fas-
mediated apoptosis. J. Biol. Chem. 271, 1841±1844.
Shaham, S., and Horvitz, H.R. (1996a). Developing Caenorhabditis
elegans neurons may contain both cell-death protective and killer
activities. Genes Dev. 10, 578±591.
Shaham, S., and Horvitz, H.R. (1996b). An alternative spliced C.
elegans ced-4 RNA encodes a novel cell death inhibitor. Cell 86,
201±208.
Shevchenko, A., Wilm, M., Vorm, O., and Mann, M. (1996). Mass
spectrometric sequencing of proteins from silver stained polyacryl-
amide gels. Anal. Chem. 68, 850±858.
Sondek, J., Bohm, A., Lambright, D.G., Hamm, H.E., and Sigler, P.B.
(1996). Crystal structure of a Ga protein bg dimer at 2.1 A resolution.
Nature 379, 369±374.
Srinivasula, S.M., Fernandes-Alnemri, T., Zangrilli, J., Robertson, N.,
Armstrong, R.C., Wang, L., Trapani, J.A., Tomaselli, K.J., Litwack,
G., and Alnemri, E.S. (1996). The Ced-3/Interleukin 1 converting
enzyme-like homolog Mch6 and the lamin-cleaving enzyme Mch2
are substrates for the apoptotic mediator CPP32. J. Biol. Chem.
271, 27099±27106.
Walker, J.E., Saraste, M., Runswick, M.J., and Gay, N.J. (1982).
Distantly related sequence in the a- and b-subunits of ATP synthase,
myosin, kinase and other ATP-requiring enzymes and a common
nucleotide binding fold. EMBO J. 1, 945±951.
Wall, M.A., Coleman, D.E., Lee, E., Iniguez-Lluhi, J., Posner, B.A.,
Gilman, A.G., and Sprang, S.R. (1995). The structure of the G protein
heterotrimer Giab1g2. Cell 83, 1047±1058.
Wang, X., Zelenski, N.G., Yang, J., Sakai, J., Brown, M.S., and
Goldstein, J.L. (1996). Cleavage of sterol regulatory element binding
proteins (SREBPs) by cpp32 during apoptosis. EMBO J. 15, 1012±
1020.
Wu, D., Wallen,H.D., andNunez, G. (1997). Interaction andregulation
of subcellular localization of CED-4 by CED-9. Science 275, 1126±
1129.
Wyllie, A.H. (1980). Glucocorticoid induced thymocyte apoptosis is
associated with endogeneous endonuclease activation. Nature 284,
555±556.
Xue, D., Shaham, S., and Horvitz, H.R. (1996). The Caenorhabditis
